Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Total Current Liabilities (2016 - 2017)

Historic Total Current Liabilities for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to $2.3 million.

  • Eledon Pharmaceuticals' Total Current Liabilities fell 6365.07% to $2.3 million in Q3 2017 from the same period last year, while for Sep 2017 it was $2.3 million, marking a year-over-year decrease of 6365.07%. This contributed to the annual value of $3.9 million for FY2016, which is 3674.13% down from last year.
  • According to the latest figures from Q3 2017, Eledon Pharmaceuticals' Total Current Liabilities is $2.3 million, which was down 6365.07% from $3.2 million recorded in Q2 2017.
  • Over the past 5 years, Eledon Pharmaceuticals' Total Current Liabilities peaked at $7.8 million during Q2 2016, and registered a low of $2.2 million during Q4 2013.
  • Its 5-year average for Total Current Liabilities is $4.7 million, with a median of $5.0 million in 2014.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 9207.79% in 2014, then tumbled by 6365.07% in 2017.
  • Over the past 5 years, Eledon Pharmaceuticals' Total Current Liabilities (Quarter) stood at $2.2 million in 2013, then skyrocketed by 92.08% to $4.2 million in 2014, then surged by 45.23% to $6.2 million in 2015, then crashed by 36.74% to $3.9 million in 2016, then plummeted by 40.84% to $2.3 million in 2017.
  • Its Total Current Liabilities was $2.3 million in Q3 2017, compared to $3.2 million in Q2 2017 and $2.4 million in Q1 2017.